Nyxoah SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is filed by Nyxoah SA, a foreign private issuer, for the month of September 2025. The filing reports a material event occurring on September 15, 2025, regarding legal action initiated by the Company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a legal development and does not contain financial performance data.
Material Changes
The primary material change reported is the initiation of a patent infringement lawsuit. On September 15, 2025, Nyxoah SA filed a lawsuit against Inspire Medical Systems, Inc. in the United States District Court for the District of Delaware.
Outlook, Risks, and Contingencies
- Legal Action: The Company alleges that Inspire Medical Systems' Inspire IV and Inspire V devices infringe three specific patents held by Nyxoah: U.S. Patent Nos. 8,700,183, 9,415,215, and 9,415,216.
- Relief Sought: The lawsuit seeks injunctive relief and damages for infringement.
- Regulatory Status: The press release attached as Exhibit 99.1 is furnished but not deemed "filed" under Section 18 of the Exchange Act, though specific sections are incorporated by reference into certain registration statements.
Key Facts for Investor Verification
- Verify the specific claims and defenses in the complaint filed in the U.S. District Court for the District of Delaware.
- Assess the potential financial impact of the lawsuit, including possible damages and legal costs, which are not quantified in this filing.
- Monitor the status of the three cited patents (Nos. 8,700,183, 9,415,215, and 9,415,216) for validity and enforceability.
- Review the attached press release (Exhibit 99.1) for additional details on the Company's strategic rationale for the litigation.